Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD-1) antibody, programmed cell death ligand 1 (PD-L1) antibody, and cytotoxic T lymphocyte associated protein 4 (CTLA-4) antibody...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | ZH |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/73efbbca7aad481c9495e49e699bda8c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|